An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome
Clinical trial NCT04442295 · COMPLETED
Trial details
- NCT number
- NCT04442295
- Sponsor
- Stoke Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2023-11-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.